HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atsushi Tanaka Selected Research

Acute Coronary Syndrome

3/2024Intracoronary Near-Infrared Spectroscopy to Predict No-Reflow Phenomenon During Percutaneous Coronary Intervention in Acute Coronary Syndrome.
1/2023Prevalence of low-attenuation plaques and statin therapy in plaque rupture type of acute coronary syndrome.
6/2022Acute coronary syndrome due to plaque erosion likely triggered by insect bites: a case series of Kounis syndrome.
10/2018The relationship between timing of prasugrel pretreatment and in-stent thrombus immediately after percutaneous coronary intervention for acute coronary syndrome: an optical coherence tomography study.
1/2018High-density lipoprotein cholesterol as a therapeutic target for residual risk in patients with acute coronary syndrome.
1/2018Effect of Early Pitavastatin Therapy on Coronary Fibrous-Cap Thickness Assessed by Optical Coherence Tomography in Patients With Acute Coronary Syndrome: The ESCORT Study.
12/2017Myeloid-related protein-8/14 in acute coronary syndrome.
1/2017Reduction of in-stent thrombus immediately after percutaneous coronary intervention by pretreatment with prasugrel compared with clopidogrel: An optical coherence tomography study.
1/2017Safety and efficacy of liraglutide treatment in Japanese type 2 diabetes patients after acute myocardial infarction: A non-randomized interventional pilot trial.
1/2017α-Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Atsushi Tanaka Research Topics

Disease

43Type 2 Diabetes Mellitus (MODY)
02/2024 - 09/2004
41Neoplasms (Cancer)
05/2024 - 03/2003
40Heart Failure
05/2024 - 04/2007
36Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
04/2024 - 05/2002
32Myocardial Infarction
06/2022 - 02/2003
22Acute Coronary Syndrome
03/2024 - 07/2003
22Thrombosis (Thrombus)
10/2022 - 02/2003
21Cardiovascular Diseases (Cardiovascular Disease)
05/2024 - 09/2004
19Infections
04/2022 - 08/2004
18Inflammation (Inflammations)
03/2024 - 01/2007
17Liver Diseases (Liver Disease)
10/2023 - 05/2002
17Sclerosing Cholangitis
04/2023 - 06/2010
17Atherosclerotic Plaque (Atheroma)
02/2021 - 01/2006
16Atherosclerosis
01/2024 - 09/2004
16Coronary Artery Disease (Coronary Atherosclerosis)
11/2023 - 09/2004
16Atrial Fibrillation
10/2023 - 04/2016
16Fibrosis (Cirrhosis)
08/2023 - 10/2007
13Chronic Renal Insufficiency
02/2024 - 10/2016
13ST Elevation Myocardial Infarction
11/2022 - 11/2010
12Hyperuricemia
01/2024 - 06/2016
12Hypertension (High Blood Pressure)
10/2023 - 01/2016
12Disease Progression
04/2023 - 09/2007
12Rupture
01/2023 - 05/2005
10Carotid Artery Diseases
11/2023 - 01/2016
10Autoimmune Diseases (Autoimmune Disease)
01/2023 - 12/2002
10Autoimmune Hepatitis
01/2022 - 04/2006
9Colorectal Neoplasms (Colorectal Cancer)
02/2024 - 01/2020
9Diabetes Mellitus
01/2024 - 01/2011
9Pathologic Constriction (Stenosis)
01/2023 - 10/2010
9Hemorrhage
12/2022 - 01/2007
8AIDS-Related Complex (ARC)
01/2023 - 06/2009
8Dyslipidemias (Dyslipidemia)
07/2021 - 12/2014
7Liver Cirrhosis (Hepatic Cirrhosis)
03/2024 - 09/2007
7Infarction (Infarctions)
03/2024 - 03/2009
7Cholangitis
03/2024 - 01/2007
7Hepatocellular Carcinoma (Hepatoma)
06/2023 - 09/2006
7Chronic Hepatitis C
07/2021 - 06/2005
6Cholestasis
03/2023 - 03/2006
6Obesity
07/2022 - 09/2004
6Fever (Fevers)
09/2021 - 06/2002
6Unstable Angina
09/2021 - 01/2006
6Stable Angina
11/2019 - 01/2006
5Pruritus (Itching)
04/2024 - 08/2012
5No-Reflow Phenomenon
03/2024 - 05/2002
5Carcinogenesis
01/2024 - 09/2006
5Neoplasm Metastasis (Metastasis)
10/2023 - 10/2018
5Proteinuria
01/2023 - 04/2003
5Heart Diseases (Heart Disease)
01/2023 - 10/2009
5Body Weight (Weight, Body)
01/2022 - 04/2016

Drug/Important Bio-Agent (IBA)

25Proteins (Proteins, Gene)FDA Link
01/2024 - 01/2005
23LipidsIBA
03/2024 - 05/2002
22Biomarkers (Surrogate Marker)IBA
01/2024 - 01/2014
21Sodium-Glucose Transporter 2 InhibitorsIBA
02/2024 - 01/2016
16Sodium-Glucose Transport ProteinsIBA
10/2023 - 01/2017
15Ursodeoxycholic Acid (Urso)FDA LinkGeneric
04/2024 - 06/2015
13EnzymesIBA
01/2023 - 04/2004
13AntibodiesIBA
01/2023 - 05/2002
12Glucose (Dextrose)FDA LinkGeneric
02/2024 - 01/2017
12CanagliflozinIBA
01/2023 - 04/2016
11Uric Acid (Urate)IBA
11/2023 - 06/2016
11CytokinesIBA
01/2023 - 12/2002
10Immunoglobulin G (IgG)IBA
08/2023 - 04/2004
10Antiviral Agents (Antivirals)IBA
06/2023 - 10/2007
10C-Reactive ProteinIBA
05/2023 - 06/2002
10AutoantibodiesIBA
01/2021 - 04/2004
9ipragliflozinIBA
02/2024 - 01/2016
9SodiumIBA
02/2024 - 01/2018
9AlbuminsIBA
10/2023 - 12/2015
9AutoantigensIBA
01/2023 - 05/2002
8FebuxostatFDA Link
01/2024 - 06/2016
8empagliflozinIBA
01/2023 - 04/2016
8Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2023 - 02/2009
7Bile Acids and Salts (Bile Acids)IBA
03/2024 - 01/2008
7Messenger RNA (mRNA)IBA
01/2023 - 06/2008
7Immunoglobulins (Immunoglobulin)IBA
10/2021 - 01/2015
6BezafibrateIBA
04/2024 - 06/2015
6Prednisolone (Predate)FDA LinkGeneric
02/2024 - 05/2006
6SteroidsIBA
01/2024 - 05/2017
6RNA (Ribonucleic Acid)IBA
01/2024 - 06/2005
6BilirubinIBA
10/2023 - 01/2008
6AntigensIBA
05/2023 - 07/2002
6Phenobarbital (Luminal)FDA Link
01/2022 - 10/2010
5Serum AlbuminIBA
04/2024 - 01/2018
5gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
03/2024 - 09/2003
5SymportersIBA
02/2024 - 01/2018
5Xanthine OxidaseIBA
01/2024 - 06/2016
5Transaminases (Aminotransferases)IBA
08/2023 - 12/2014
5DNA (Deoxyribonucleic Acid)IBA
04/2023 - 06/2002
5AnticoagulantsIBA
02/2023 - 11/2020
5glimepiride (Amarel)FDA LinkGeneric
01/2023 - 04/2016
5Therapeutic UsesIBA
10/2022 - 10/2009
5CholesterolIBA
02/2022 - 01/2008
5Hypoglycemic Agents (Hypoglycemics)IBA
01/2021 - 01/2016

Therapy/Procedure

54Therapeutics
05/2024 - 03/2004
31Percutaneous Coronary Intervention
03/2024 - 02/2003
21Stents
01/2023 - 11/2003
11Catheter Ablation
11/2020 - 04/2016
10Liver Transplantation
01/2022 - 12/2016
8Drug Therapy (Chemotherapy)
02/2022 - 06/2002
5Immunotherapy
01/2023 - 01/2017